
==== Front
Biomed Rep
Biomed Rep
BR
Biomedical Reports
2049-9434
2049-9442
D.A. Spandidos

BR-21-5-01841
10.3892/br.2024.1841
Review
Unlocking the potential of capsaicin in oral health (Review)
Yohana Winny
Rafisa Anggun
Department of Oral Biology, Faculty of Dentistry, Universitas Padjadjaran, Sumedang, West Java 45363, Indonesia
Correspondence to: Professor Winny Yohana, Department of Oral Biology, Faculty of Dentistry, Universitas Padjadjaran, Ir. Soekarno Street Km 21, Jatinangor, Sumedang, West Java 45363, Indonesia wangqiang@wust.edu.cn winny.yohana@unpad.ac.id
11 2024
22 8 2024
22 8 2024
21 5 15315 3 2024
05 8 2024
Copyright: © 2024 Yohana and Rafisa.
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Capsaicin is a bioactive compound found prominently in Capsicum annuum L. plants and takes on a pivotal role in their characteristic spiciness. Previous studies have delved into the potential analgesic effect of capsaicin in various oral conditions, such as oral neuropathic pain, trigeminal neuralgia, oral mucositis, temporomandibular joint disorders and burning mouth syndrome. Capsaicin has also demonstrated promise in inhibiting the proliferation of different oral cancer cell lines. Its antimicrobial properties have also been shown to inhibit the growth of oral pathogens associated with dental caries, periodontitis and oral candidiasis. However, to harness its benefits effectively, more studies are required to establish optimal dosages for pain relief while minimizing adverse effects. In addition, investigation of the effect of capsaicin on nonpathogenic oral bacteria and viruses is warranted. Human-based research is crucial for elucidating the biomolecular mechanisms underlying the properties of capsaicin, potentially leading to the development of more effective interventions for oral health problems.

analgesic
anticancer
anti-inflammatory
antimicrobial
capsaicin
Capsicum annuum
oral health
Funding: No funding was received.
==== Body
pmc1. Introduction

Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a bioactive compound of considerable importance among natural constituents found in Capsicum plants (1-3). Capsaicin, present in the Capsicum annuum L. plant, imparts the characteristic spiciness to this species. This plant is a member of the Solanaceae family, which is one of the earliest cultivated crops in the Western hemisphere (4). The growing societal consumption of Capsicum annuum is underscored by its substantial nutritional value, which serves as a rich source of essential vitamins such as C, E and provitamin A (carotene), renowned for their antioxidant properties (5). In addition, it offers a plentiful supply of neutral phenolic compounds, including luteolin, quercetin and capsaicinoids (6,7).

Capsaicin is acknowledged for its potential analgesic properties and therapeutic applications in the management of inflammation and inflammatory diseases. The underlying mechanism predominantly centers on the interaction between capsaicin and its receptor, transient receptor potential vanilloid 1 (TRPV1). Its molecular basis was elucidated by Caterina et al (8) in 1997, igniting significant interest in manipulating capsaicin and its receptor pharmacologically (9). Clinical studies have explored capsaicin as a topical treatment for various pain conditions, such as osteoarthritis, rheumatoid arthritis, postherpetic neuralgia, psoriasis, and diabetic neuropathy (10,11).

Furthermore, capsaicin exhibits in vitro antibacterial activity against a spectrum of pathogens, such as Streptococcus pyogenes (12), Porphyromonas gingivalis (13), Vibrio cholerae (14) and Staphylococcus aureus (15,16), reflecting its potential in the treatment of pathogenic bacterial infections and alleviation of antimicrobial resistance. In addition, capsaicin has exhibited promise as a chemopreventive agent for cancer. Its combination with radiotherapy and chemotherapy drugs shows the potential to enhance patient sensitivity to these treatments, reduce required dosages and improve overall tolerance to cancer therapy (17,18).

The multifaceted attributes of capsaicin, encompassing its analgesic, anti-inflammatory, antimicrobial and anticancer properties, hold significant promise in an oral health context. This review aimed to explore relevant publications that investigate the utilization of capsaicin as a therapeutic agent for oral conditions and the preservation of oral well-being.

2. Capsaicin biosynthesis

The biosynthesis pathway of capsaicin (Fig. 1) involves two distinct routes: i) Through the synthesis of vanillylamine via the phenylpropanoid shikimate/arogenate pathway; and ii) through the branched fatty acid derived from valine (19-21). Key enzymes proposed to participate in the phenylpropanoid pathway include phenylalanine ammonia lyase, cinnamate 4-hydroxylase, 4-coumaroyl-CoA ligase, coumarate 3-hydroxylase, hydroxycinnamoyl transferase, caffeoyl-coenzyme A (CoA) O-methyltransferase, hydroxycinnamoyl-CoA hydratase/lyase, putative aminotransferase and acyltransferase (21-26). For the mechanisms underlying the synthesis of branched-chain fatty acids, studies have hypothesized that a desaturase is involved in the conversion of 8-methylnonanoic acid into 8-methyl-6-nonenoic acid (24,27). Mazourek et al (21) proposed the inclusion of the biosynthesis of amino acids that leads to capsacinoids in the branched-chain fatty acid biosynthetic pathway.

Researchers have employed various techniques to manipulate culture strategies and thus enhance capsaicinoid biosynthesis. Among these strategies, osmotic stress has become an effective method, resulting in the highest product accumulation, followed by precursor feeding (20). In addition, the duration of exposure to these treatments significantly influences the level of capsaicin biosynthesis (20).

3. Analgesic and anti-inflammatory properties

Studies have comprehensively elucidated the foundational mechanism underlying the analgesic and anti-inflammatory properties of capsaicin (Fig. 2), whereby capsaicin selectively interacts with the TRPV1 cation channel (28). This channel exhibits high permeability to calcium (Ca2+) ions and detects potentially noxious stimuli. This interaction results in the opening of Ca2+ channels and the subsequent neurotransmitter release. This calcium-dependent process culminates in the depletion of substance P and desensitization of primary afferent fibers to painful stimuli, inducing analgesia (28). Concurrently, capsaicin exhibits anti-inflammatory properties by reducing proinflammatory cytokines and vascular permeability (29). Capsaicin can deactivate nuclear transcription factor κB, thereby inhibiting prostaglandin E-2 and nitric oxide production, subsequently attenuating vascular leakage and modulating inflammatory cell migration mediated by tumor necrosis factor-α and interleukin (IL)-1(30).

Orofacial neuropathic pain

Capsaicin is commonly administered topically to treat chronic pain associated with osteoarthritis, rheumatoid arthritis, diabetic neuropathy and nondiabetic peripheral neuropathy (10,31). The pain-relieving effects of low-dose topical capsaicin (0.025, 0.050 and 0.075%) were also demonstrated in conditions such as oral neuropathic pain and trigeminal neuralgia (32-34). These capsaicin cream formulations are also available over the counter (35). However, the efficacy of lower doses appears to be moderate and patient compliance with this therapy is often hindered by the need for daily repetitive application and the potential for irritation, which can manifest as sensations of burning, stinging or itching (31,36). Therefore, products containing higher concentrations of capsaicin were suggested to relieve pain after a single topical application (37). Higher capsaicin doses may desensitize cutaneous and subcutaneous receptors, resulting in reduced responsiveness to various sensory stimuli (3).

Several studies have tested the effectiveness of 8% capsaicin patch in managing orofacial neuropathic pain. In a case report, Sayanlar et al (38) revealed that a single application of the 8% capsaicin topical patch on a patient diagnosed with trigeminal postherpetic neuralgia demonstrated a substantial effect on reducing the pain level and area. Gaul and Resch (39) reported the effectiveness and safety of the application of 8% capsaicin patch in the treatment of four cases of neuropathic pain in the head and facial region caused by surgery or herpes zoster infection. Sustained reduction in pain was noted in three of the patients; however, two of them required repeated applications of capsaicin (39). Similarly, Martinez et al (40) reported the success of repeated applications of 8% capsaicin patch in managing pain in two patients with trigeminal neuralgia. These three studies have used a similar method, which was applying 8% capsaicin for 60 min in the painful area and ensuring eye protection such as using safety goggles, a compress and plaster, and eye dressing and cream (38-40).

Burning mouth syndrome (BMS) is a chronic neuropathic pain common in post-menopausal women (41). Several studies have explored the effectiveness of capsaicin in managing BMS symptoms using capsaicin therapies in different durations (ranging from 1 month to 1 year), concentrations (0.01, 0.02, 0.025 and 0.25%), and forms (capsule, gel and mouth rinse). All of these studies have reported that capsaicin successfully relieved BMS-related pain and discomfort (42-45). A study found no significant difference in the effectiveness of 0.01 and 0.025% capsaicin gels in reducing BMS symptoms, which indicates that the 0.01% gel is adequate to activate the analgesic effect of capsaicin for BMS (44).

Oral ulcers

Capsaicin in chili peppers was once proposed as a component that could cause ulcers, particularly in the gastrointestinal tract (46,47). However, later studies have found that it acted contrarily, i.e., capsaicin helps in preventing and relieving ulcers by inhibiting gastric acid secretion and stimulating mucus secretions and blood flow (47).

Despite studies discussing the effect of capsaicin on gastric or intestinal ulcers, published studies involving capsaicin and oral ulcers are limited. A study on 11 patients who underwent chemotherapy or radiotherapy reported the significant analgesic effect of orally administered capsaicin on oral mucositis pain; however, the effect was temporary in most patients (48). In an animal study, Jiang et al (49) reported a healing rate of 97.8% on the oral ulcer model in rats after 7 days of treatment with 0.05% capsaicin candy, which was significantly higher than those in groups receiving a placebo and dexamethasone. The study also reported a high inflammatory effect of capsaicin, as it reduces the expression of TNF-α and IL-6(49). This finding holds significance in the treatment of oral ulcers and needs further investigation.

Temporomandibular disorders (TMDs)

TMDs are considered neuropathic and idiopathic pain disorders (50,51). In a randomized controlled study involving 30 patients with unilateral pain in the temporomandibular joint area, Winocur et al (52) found no significant difference in the pain relief effect between the group using 0.025% capsaicin cream four times a day and the placebo group, despite the significant improvement in pain parameters throughout the experiment (4 weeks). Later, Campbell et al (53) demonstrated that a higher concentration of capsaicin (8% cream) was effective in relieving pain in patients with TMDs, despite the shorter experiment duration (1 week). However, the authors also reported that the finding may be biased by the small sample size and inclusion of female subjects only due to funding and difficulty in participant recruitment (53).

4. Anticancer properties

In experimental studies utilizing cell cultures and animal models, capsaicin consistently demonstrated the capacity to inhibit oral cancer cell growth and induce apoptosis (54). Table I lists several in vitro and in vivo investigations that explored the potential of capsaicin as a treatment agent for oral cancer (55-61). The proposed mechanism underlying the anticancer activity of capsaicin on oral cancer from several studies is shown in Fig. 3 (54-61). Capsaicin exerts anti-proliferative effects on oral epithelial dysplasia, leading to a reduction in its incidence, severity and aggressiveness (55,58). Capsaicin disrupts the mitochondrial membrane potential in oral squamous cell carcinomas by triggering endoplasmic reticulum (ER) stress and increasing the ratio of Bax/Bcl-2, leading to the release of cytochrome c and apoptosis-inducing factor from mitochondria (56,57). This process activates caspase-3, -7 and -9, resulting in apoptosis (56,57). Furthermore, capsaicin interacts with tumor-associated NADH oxidase (tNOX), promoting both autophagy and apoptosis in cancer cells (59). Capsaicin also enhances the sensitivity of cancer cells to anticancer drugs by increasing autophagy and reducing ribophorin II protein levels (60). However, studies suggest that capsaicin therapy for oral cancer is dose-dependent and its efficacy may be compromised by bacterial antigens (56,61). Considering its multifaceted effects on cellular pathways and its potential implications for developing therapeutic strategies for oral cancer management, further investigations are warranted to truly understand the anti-oral cancer mechanisms of capsaicin.

Oral epithelial dysplasia

Tanaka et al (55) found that a 500-ppm capsaicin diet reduced the incidence and multiplicity of tongue dysplasia on 4-NQO-induced tongue tumorigenesis in male rats. In another in vivo study, Mohamed and AlQarni (58) experimentally induced hamster buccal pouch carcinogenesis and demonstrated that capsaicin-treated hamsters exhibited slower cell proliferation and reduced incidence and severity of oral epithelial dysplasia.

Oral squamous cell carcinoma

Ip et al (56) found that increasing capsaicin doses and longer incubation periods enhanced the induction of apoptosis in NPC-TW 039 cells. Among the doses tested (0, 200, 250, 300 and 400 µM) and incubation times (12, 24, 36 and 48 h), treatment with 400 µM capsaicin resulted in the most significant decrease in cell viability, reaching nearly 65% after 48 h of treatment (56).

In another in vitro investigation focusing on oral squamous cell carcinoma of Asian origin (ORL-48), Kamaruddin et al (57) revealed that capsaicin treatment induced apoptosis, leading to apoptotic DNA fragmentation. In addition, the cell viability rate was the lowest, whereas the apoptosis rate was the highest after 72 h of treatment compared with that at 48 h (57).

Chang et al (59) investigated the interplay between apoptosis and autophagy in p53-mutated HSC-3 and p53-functional SAS cells treated with different concentrations of capsaicin. They revealed that capsaicin engaged with tumor-associated NADH oxidase (tNOX) to cause its degradation, and inhibition of sirtuin 1 (SIRT1) deacetylase activity, which enhanced unc-51-like autophagy activating kinase 1 (ULK1) acetylation and autophagy activation in p53-functional SAS cells (59). Capsaicin induced autophagy and apoptosis in p53-mutated HSC-3 cells, with autophagy inhibiting but later facilitating apoptosis. Reduced tNOX and SIRT1 levels, combined with high levels of ULK1 and c-Myc acetylation, reactivated the tumor necrosis factor-related apoptosis-inducing ligand pathway, resulting in apoptosis (59).

Huang et al (60) investigated capsaicin-induced sensitization to four chemotherapeutic agents (5-fluorouracil, cisplatin, docetaxel and doxorubicin) in oral squamous cell carcinoma (HSC-3 and SAS) and discovered that 200 µM capsaicin did not significantly induce apoptosis but caused ER stress and autophagy by suppressing ribophorin II. Furthermore, capsaicin in combination with anticancer agents sensitizes cancer cells to these agents and inhibits their viability by increasing necroptosis markers such as mixed lineage kinase domain-like protein and receptor-interacting protein kinase 3(60).

5. Antimicrobial properties

The chili fruit is rich in phenolic compounds, predominantly flavonoids and capsaicin, alongside phenolic acids such as tamarind ferulic, coumaric acid and cinnamic acid (62,63). These secondary metabolites are positively associated with antioxidant and antimicrobial activities, potentially interfering with the synthesis of bacterial cell membranes (64). Numerous studies have proved the antimicrobial properties of capsaicin, providing a promising standpoint as an alternative strategy against antimicrobial resistance (65).

Dental caries

Santos et al (66) evaluated the inhibitory effects of capsaicin, dihydrocapsaicin and four synthetic capsaicinoid derivatives against Streptococcus mutans, a key contributor to cariogenic biofilm. They revealed that these compounds had a minimum inhibitory concentration (MIC) ranging from 1.25 to 5.0 µg/ml for these bacteria (66). Similarly, Gu et al (67) demonstrated the potent action of capsaicin against cariogenic bacterial strains, including S. mutans, Actinomyces viscosus, Lactobacillus and Streptococcus sanguis, by inhibiting acid production and biofilm formation. The MIC values of capsaicin were 50 µg/ml for S. mutans, A. viscosus and Lactobacillus and 25 µg/ml for S. sanguis (67). However, Doğan and Tunçer (68) reported contrasting findings: Although capsaicin did not inhibit the growth of S. mutans, it suppressed the growth of the oral probiotic Streptococcus salivarius M18 at concentrations >100 µg/ml. These discrepancies underscore the need for further studies into the nuanced effects of capsaicin, considering factors such as compound nature and concentration, and its effect on nonpathogenic oral bacteria.

Periodontal diseases

Previous studies have also highlighted the efficacy of capsaicin against periodontitis-associated pathogens, notably P. gingivalis. An in vitro study by Zhou et al (13) demonstrated the inhibitory effect of capsaicin on the growth of P. gingivalis and the expression of NF-ĸB p65, indicating its potential to inhibit alveolar bone resorption. In addition, animal experimental studies, such as that by Cong et al (69), revealed that topical application of 0.075% capsaicin over the submandibular gland increased salivary secretion, which could have a significant utility in the control of microbial colonization.

Candidiasis

Investigations into the antifungal properties of capsaicin, particularly against Candida albicans, a common cause of oral candidiasis infections, have yielded promising results (65). Nascimento et al (70) found that at the MIC of 25 µg/ml, capsaicin inhibited the growth of C. albicans. Furthermore, Omolo et al (71) highlighted greater susceptibility of C. albicans to capsaicin than certain bacterial strains. Behbehani et al (72) proposed the mechanism of capsaicin's antifungal activity, suggesting its ability to disrupt C. albicans cell wall integrity by inhibiting ergosterol biosynthesis. In addition, the combination of capsaicin and fluconazole exhibited enhanced efficacy, potentially aiding in preventing fluconazole resistance (72).

Viral infection of the oral cavity

Despite studies investigating the potential antiviral properties of capsaicin, particularly against Herpes simplex virus (73), Lassa virus (74,75) and severe acute respiratory syndrome coronavirus 2(75), research on its effects on oral viruses is limited. Nevertheless, considering capsaicin's potential to inhibit the replication of certain viruses because of its ability to modulate immune and inflammatory responses (76), further related research could provide valuable insight into its therapeutic potential for viral infections in the oral cavity.

6. Side effects

Mild to moderate burning sensation, stinging, itching, redness and pain in the treated area are among the main reported side effects of topical treatment of capsaicin for orofacial pain and disorders, which are self-limiting and short term (37-39,43). Studies have recommended administering a local anesthetic before applying topical capsaicin to minimize pain perception and control the initial burning sensation (32,35). Ensuring the patch fits the contour of the affected skin and avoiding contact with the eyes are also essential for the treatment's safety (38).

However, topical therapy requires repeated applications daily, which could expose patients to repeated potential irritations from side effects, reducing the patient's compliance with the therapy (31,36). Furthermore, capsaicin's bitter taste and unpleasant consistency contributed to lower compliance with the therapy, particularly when applied on the tongue (42).

In addition, further research on the intraoral use of capsaicin is warranted to investigate potential side effects on the gastrointestinal system. Petruzzi et al (42) reported mild gastric pain in patients treated with oral systemic capsaicin for BMS symptoms. Jørgensen and Pedersen (44) reported that several patients discontinued the capsaicin gel therapy that required application on the tongue for treating BMS because of nausea and sore throat.

7. Conclusion and future perspectives

Capsaicin holds significant promise for enhancing oral health owing to its analgesic, anti-inflammatory, anticancer and antimicrobial effects. However, more studies are necessary to determine the optimal dosage of capsaicin for alleviating oral pain while minimizing adverse effects. Further investigations on the effect of capsaicin on nonpathogenic oral bacteria and oral viruses are also warranted. Human-based research is also needed to gain a deeper understanding of the biomolecular mechanisms underlying the properties of capsaicin. These research advancements could lead to the development of more effective and targeted interventions for oral health issues.

Acknowledgements

Not applicable.

Availability of data and materials

Not applicable.

Authors' contributions

The study was conceptualized by WY. WY and AR significantly contributed to data collection, manuscript drafting, reviewing and editing. Each author has thoroughly reviewed and approved the final version of the manuscript. Data authentication is not applicable.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Figure 1 Capsaicin biosynthesis pathway. CoA, coenzyme A.

Figure 2 Mechanism of action of capsaicin on pain perception and inflammation (28-30). NO, nitric oxide, PGE, prostaglandin E; TRPV1, transient receptor potential vanilloid 1.

Figure 3 Mechanism of action of capsaicin on oral cancer (54-61). ER, endoplasmic reticulum; ROS, reactive oxygen species; PCNA, proliferating cell nuclear antigen; ssDNA, single-stranded DNA; tNOX, tumor-associated NADH oxidase; SIRT1, sirtuin 1; ULK1, unc-51-like autophagy activating kinase 1.

Table I Studies on capsaicin treatment for oral cancer.

Author(s), year	Cell line(s)/test species	Capsaicin treatment	Effects	(Refs.)	
Tanaka et al, 2002	4-NQO-induced tongue tumorigenesis in four-week-old male F344 rats	Diets containing 500 ppm capsaicin for 10 and 28 weeks	Reduced incidence of carcinoma and severe dysplasia, as well as increased apoptotic index and proliferative index of squamous cell carcinoma	(55)	
Ip et al, 2012	Human nasopharyngeal carcinoma (NPC-TW 039)	Various doses of capsaicin (0, 200, 250, 300 and 400 µM) for different incubation times (12, 24, 36 and 48 h)	Induced ER stress, increased ROS production, enhanced apoptosis induction with higher doses and longer incubation periods	(56)	
Kamaruddin et al, 2019	Oral squamous cell carcinoma of Asian origin (ORL-48)	Various doses of capsaicin (50, 100, 150, 200, 250, 300 and 350 µM) for different incubation times (24, 48 and 72 h)	Induced apoptosis via disruption of mitochondrial membrane potential, activation of caspase-3, -7 and -9, intrinsic apoptotic pathway activation, lowest cell viability and highest apoptosis percentage with longer incubation periods	(57)	
Mohamed and AlQarni, 2019	Experimentally induced buccal pouch carcinogenesis in five-week-old golden (Syrian) male hamsters	Water containing 10 ppm capsaicin for 9 weeks	Slower cell proliferation, reduced tumor aggressiveness and lower oral epithelial dysplasia	(58)	
Chang et al, 2020	p53-mutated HSC-3 and p53-functional SAS cells	Different concentrations of capsaicin for 24 or 48 h; 2 mM capsaicin for 1 h incubation at the end of treatment	Induced both autophagy and apoptosis in p53-mutated HSC-3 cells, but only autophagy in p53-functional SAS cells	(59)	
Huang et al, 2021	Oral squamous cell carcinoma (HSC-3 and SAS)	200 µM capsaicin for 30 min	Induced ER stress and autophagy by suppressing ribophorin II, increased sensitivity of cancer cells to chemotherapeutic agents, inhibited viability by increasing necroptosis markers (phospho-MLKL and phospho-RIP3)	(60)	
Chakraborty et al, 2021	Oral cancer cells Cal 27	Capsaicin treatments ranged from 0 to 150 µM with a 24-h incubation time. Bacterial antigens, LPS and LTA, were introduced to cancer cells before and/or during capsaicin administration	Exposure to bacterial antigens resulted in reduced death and metabolic inhibition of cancer cells, as well as decreased SOCS3 gene expression, compared to capsaicin treatment alone	(61)	
4-NQO, 4-nitroquinoline 1-oxide; ER, endoplasmic reticulum; ROS, reactive oxygen species; MKLK, mixed lineage kinase domain-like protein; RIP3, receptor-interacting protein kinase 3; LPS, lipopolysaccharide; LTA, lipoteichoic acid; SOCS3, cytokine signalling 3.
==== Refs
References

1 Reyes-Escogido Mde L Gonzalez-Mondragon EG Vazquez-Tzompantzi E Chemical and pharmacological aspects of capsaicin Molecules 16 1253 1270 2011 10.3390/molecules16021253 21278678
2 Adetunji TL Olawale F Olisah C Adetunji AE Aremu AO Capsaicin: A Two-Decade Systematic Review of Global Research Output and Recent Advances Against Human Cancer Front Oncol 12 908487 2022 10.3389/fonc.2022.908487 35912207
3 Fattori V Hohmann MS Rossaneis AC Pinho-Ribeiro FA Verri WA Capsaicin: Current Understanding of Its Mechanisms and Therapy of Pain and Other Pre-Clinical and Clinical Uses Molecules 21 844 2016 10.3390/molecules21070844 27367653
4 Chapa-Oliver AM Mejía-Teniente L Capsaicin: From Plants to a Cancer-Suppressing Agent Molecules 21 931 2016 10.3390/molecules21080931 27472308
5 Alonso-Villegas R González-Amaro RM Figueroa-Hernández CY Rodríguez-Buenfil IM The Genus Capsicum: A Review of Bioactive Properties of Its Polyphenolic and Capsaicinoid Composition Molecules 28 4239 2023 10.3390/molecules28104239 37241977
6 Bal S Sharangi AB Upadhyay TK Khan F Pandey P Siddiqui S Saeed M Lee HJ Yadav DK Biomedical and Antioxidant Potentialities in Chilli: Perspectives and Way Forward Molecules 27 6380 2022 10.3390/molecules27196380 36234927
7 Allam AE Suppression of cytokine production by newly isolated flavonoids from pepper Fitoterapia 151 104903 2021 10.1016/j.fitote.2021.104903 33812999
8 Caterina MJ Schumacher MA Tominaga M Rosen TA Levine JD Julius D The capsaicin receptor: A heat-activated ion channel in the pain pathway Nature 389 816 824 1997 10.1038/39807 9349813
9 Basith S Cui M Hong S Choi S Harnessing the Therapeutic Potential of Capsaicin and Its Analogues in Pain and Other Diseases Molecules 21 966 2016 10.3390/molecules21080966 27455231
10 Persson MS Fu Y Bhattacharya A Goh SL van Middelkoop M Bierma-Zeinstra SM Walsh D Doherty M Zhang W OA Trial Bank Consortium Relative efficacy of topical non-steroidal anti-inflammatory drugs and topical capsaicin in osteoarthritis: Protocol for an individual patient data meta-analysis Syst Rev 5 165 2016 10.1186/s13643-016-0348-8 27686859
11 Srinivasan K Biological Activities of Red Pepper (Capsicum annuum) and Its Pungent Principle Capsaicin: A Review Crit Rev Food Sci Nutr 56 1488 1500 2016 10.1080/10408398.2013.772090 25675368
12 Marini E Magi G Mingoia M Pugnaloni A Facinelli B Antimicrobial and Anti-Virulence Activity of Capsaicin Against Erythromycin-Resistant, Cell-Invasive Group A Streptococci Front Microbiol 6 1281 2015 10.3389/fmicb.2015.01281 26617603
13 Zhou Y Guan X Zhu W Liu Z Wang X Yu H Wang H Capsaicin inhibits Porphyromonas gingivalis growth, biofilm formation, gingivomucosal inflammatory cytokine secretion, and in vitro osteoclastogenesis Eur J Clin Microbiol Infect Dis 33 211 219 2014 10.1007/s10096-013-1947-0 23955115
14 Chatterjee S Asakura M Chowdhury N Neogi SB Sugimoto N Haldar S Awasthi SP Hinenoya A Aoki S Yamasaki S Capsaicin, a potential inhibitor of cholera toxin production in Vibrio cholerae FEMS Microbiol Lett 306 54 60 2010 10.1111/j.1574-6968.2010.01931.x 20337712
15 Qiu J Niu X Wang J Xing Y Leng B Dong J Li H Luo M Zhang Y Dai X Capsaicin protects mice from community-associated methicillin-resistant Staphylococcus aureus pneumonia PLoS One 7 e33032 2012 10.1371/journal.pone.0033032 22427935
16 Kalia NP Mahajan P Mehra R Nargotra A Sharma JP Koul S Khan IA Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus J Antimicrob Chemother 67 2401 2408 2012 10.1093/jac/dks232 22807321
17 Zhang S Wang D Huang J Hu Y Xu Y Application of capsaicin as a potential new therapeutic drug in human cancers J Clin Pharm Ther 45 16 28 2020 10.1111/jcpt.13039 31545523
18 Nie J Zhao C Deng LI Chen J Yu B Wu X Pang P Chen X Efficacy of traditional Chinese medicine in treating cancer Biomed Rep 4 3 14 2016 10.3892/br.2015.537 26870326
19 Díaz J Pomar F Bernal A Merino F Peroxidases and the metabolism of capsaicin in Capsicum annuum L Phytochem Rev 3 141 157 2004
20 Kehie M Kumaria S Tandon P Ramchiary N Biotechnological advances on in vitro capsaicinoids biosynthesis in capsicum: a review Phytochem Rev 14 189 201 2015
21 Mazourek M Pujar A Borovsky Y Paran I Mueller L Jahn MM A dynamic interface for capsaicinoid systems biology Plant Physiol 150 1806 1821 2009 10.1104/pp.109.136549 19553373
22 Suzuki T Fujiwake H Iwai K Intracellular localization of capsaicin and its analogues, capsaicinoid, in Capsicum fruit 1. Microscopic investigation of the structure of the placenta of Capsicum annuum var. annuum cv. Karayatsubusa Plant Cell Physiol 21 839 853 1980
23 Sukrasno N Yeoman MM Phenylpropanoid metabolism during growth and development of Capsicum frutescens fruits Phytochem 32 839 844 1993
24 Stewart C Jr Kang BC Liu K Mazourek M Moore SL Yoo EY Kim BD Paran I Jahn MM The Pun1 gene for pungency in pepper encodes a putative acyltransferase Plant J 42 675 688 2005 10.1111/j.1365-313X.2005.02410.x 15918882
25 Zhang ZX Zhao SN Liu GF Huang ZM Cao ZM Cheng SH Lin SS Discovery of putative capsaicin biosynthetic genes by RNA-Seq and digital gene expression analysis of pepper Sci Rep 6 34121 2016 10.1038/srep34121 27756914
26 Arce-Rodríguez ML Ochoa-Alejo N Biochemistry and molecular biology of capsaicinoid biosynthesis: Recent advances and perspectives Plant Cell Rep 38 1017 1030 2019 10.1007/s00299-019-02406-0 30941502
27 Blum E Mazourek M O'Connell M Curry J Thorup T Liu K Jahn M Paran I Molecular mapping of capsaicinoid biosynthesis genes and quantitative trait loci analysis for capsaicinoid content in Capsicum Theor Appl Genet 108 79 86 2003 10.1007/s00122-003-1405-y 13679988
28 Clark R Lee SH Anticancer Properties of Capsaicin Against Human Cancer Anticancer Res 36 837 843 2016 26976969
29 Alawi K Keeble J The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation Pharmacol Ther 125 181 195 2010 10.1016/j.pharmthera.2009.10.005 19896501
30 Kim CS Kawada T Kim BS Han IS Choe SY Kurata T Yu R Capsaicin exhibits anti-inflammatory property by inhibiting IkB-a degradation in LPS-stimulated peritoneal macrophages Cell Signal 15 299 306 2003 10.1016/s0898-6568(02)00086-4 12531428
31 Derry S Lloyd R Moore RA McQuay HJ Topical capsaicin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. CD007393, 2009.
32 Epstein JB Marcoe JH Topical application of capsaicin for treatment of oral neuropathic pain and trigeminal neuralgia Oral Surg Oral Med Oral Pathol 77 135 140 1994 10.1016/0030-4220(94)90275-5 8139830
33 Ellison N Loprinzi CL Kugler J Hatfield AK Miser A Sloan JA Wender DB Rowland KM Molina R Cascino TL Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients J Clin Oncol 15 2974 2980 1997 10.1200/JCO.1997.15.8.2974 9256142
34 Fusco BM Alessandri M Analgesic effect of capsaicin in idiopathic trigeminal neuralgia Anesth Analg 74 375 377 1992 10.1213/00000539-199203000-00011 1539818
35 Padilla M Clark GT Merrill RL Topical medications for orofacial neuropathic pain: A review J Am Dent Assoc 131 184 195 2000 10.14219/jada.archive.2000.0146 10680386
36 Mason L Moore RA Derry S Edwards JE McQuay HJ Systematic review of topical capsaicin for the treatment of chronic pain BMJ 328 991 2004 10.1136/bmj.38042.506748.EE 15033881
37 Peppin JF Pappagallo M Capsaicinoids in the treatment of neuropathic pain: A review Ther Adv Neurol Disord 7 22 32 2014 10.1177/1756285613501576 24409200
38 Sayanlar J Guleyupoglu N Portenoy R Ashina S Trigeminal postherpetic neuralgia responsive to treatment with capsaicin 8% topical patch: A case report J Headache Pain 13 587 589 2012 10.1007/s10194-012-0467-0 22717586
39 Gaul C Resch S Application of the capsaicin 8% cutaneous patch in neuropathic pain of the head and face: A case series Cephalalgia 35 545 550 2015 10.1177/0333102414550107 25217483
40 Martinez MLC Adan N Carballude A Lamelas L Villar E Seoane PR Capsaicin 8% patch in trigeminal neuralgia: Case reports Aust Med J 12 98 102 2019
41 Jääskeläinen SK Is burning mouth syndrome A neuropathic pain condition? Pain 159 610 613 2018 10.1097/j.pain.0000000000001090 29257770
42 Petruzzi M Lauritano D De Benedittis M Baldoni M Serpico R Systemic capsaicin for burning mouth syndrome: Short-term results of a pilot study J Oral Pathol Med 33 111 114 2004 10.1111/j.1600-0714.2004.0194n.x 14720197
43 Silvestre FJ Silvestre-Rangil J Tamarit-Santafé C Bautista D Application of a capsaicin rinse in the treatment of burning mouth syndrome Med Oral Patol Oral Cir Bucal 17 e1 e4 2012 10.4317/medoral.17219 21743415
44 Jørgensen MR Pedersen AM Analgesic effect of topical oral capsaicin gel in burning mouth syndrome Acta Odontol Scand 75 130 136 2017 10.1080/00016357.2016.1269191 28007005
45 Azzi L Croveri F Pasina L Porrini M Vinci R Manfredini M Tettamanti L Tagliabue A Silvestre Rangil J Spadari F A ‘burning’ therapy for burning mouth syndrome: Preliminary results with the administration of topical capsaicin J Biol Regul Homeost Agents 31 (2 Suppl 1) 89 95 2017 28691458
46 Mann NS Capsaicin induced acute erosive gastritis: Its prevention by antacid, metiamide and cimetidine J Ky Med Assoc 75 71 73 1977 833485
47 Satyanarayana MN Capsaicin and gastric ulcers Crit Rev Food Sci Nutr 46 275 328 2006 10.1080/1040-830491379236 16621751
48 Berger A Henderson M Nadoolman W Duffy V Cooper D Saberski L Bartoshuk L Oral capsaicin provides temporary relief for oral mucositis pain secondary to chemotherapy/radiation therapy J Pain Symptom Manage 10 243 248 1995 10.1016/0885-3924(94)00130-D 7629418
49 Jiang H Yu X Fang R Xiao Z Jin Y 3D printed mold-based capsaicin candy for the treatment of oral ulcer Int J Pharm 568 118517 2019 10.1016/j.ijpharm.2019.118517 31306713
50 Diatchenko L Nackley AG Slade GD Fillingim RB Maixner W Idiopathic pain disorders - Pathways of vulnerability Pain 123 226 230 2006 10.1016/j.pain.2006.04.015 16777329
51 Pedullà E Meli GA Garufi A Mandalà ML Blandino A Cascone P Neuropathic pain in temporomandibular joint disorders: Case-control analysis by MR imaging AJNR Am J Neuroradiol 30 1414 1418 2009 10.3174/ajnr.A1575 19357384
52 Winocur E Gavish A Halachmi M Eli I Gazit E Topical application of capsaicin for the treatment of localized pain in the temporomandibular joint area J Orofac Pain 14 31 36 2000 11203735
53 Campbell BK Fillingim RB Lee S Brao R Price DD Neubert JK Effects of High-Dose Capsaicin on TMD Subjects:A Randomized Clinical Study JDR Clin Trans Res 2 58 65 2017 10.1177/2380084416675837 28879245
54 Mosqueda-Solís A Lafuente-Ibáñez de Mendoza I Aguirre-Urizar JM Mosqueda-Taylor A Capsaicin intake and oral carcinogenesis: A systematic review Med Oral Patol Oral Cir Bucal 26 e261 e268 2021 10.4317/medoral.24570 33609025
55 Tanaka T Kohno H Sakata K Yamada Y Hirose Y Sugie S Mori H Modifying effects of dietary capsaicin and rotenone on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis Carcinogenesis 23 1361 1367 2002 10.1093/carcin/23.8.1361 12151355
56 Ip SW Lan SH Lu HF Huang AC Yang JS Lin JP Huang HY Lien JC Ho CC Chiu CF Capsaicin mediates apoptosis in human nasopharyngeal carcinoma NPC-TW 039 cells through mitochondrial depolarization and endoplasmic reticulum stress Hum Exp Toxicol 31 539 549 2012 10.1177/0960327111417269 21859781
57 Kamaruddin MF Hossain MZ Mohamed Alabsi A Mohd Bakri M The Antiproliferative and Apoptotic Effects of Capsaicin on an Oral Squamous Cancer Cell Line of Asian Origin, ORL-48 Medicina (Kaunas) 55 322 2019 10.3390/medicina55070322 31261824
58 Mohamed MA AlQarni AA Chemopreventive effect of capsaicin in experimentally induced hamster buccal pouch carcinogenesis (Immunohistochemical study Bcl-2) Egypt Dent J 65 1237 1243 2019
59 Chang CF Islam A Liu PF Zhan JH Chueh PJ Capsaicin acts through tNOX (ENOX2) to induce autophagic apoptosis in p53-mutated HSC-3 cells but autophagy in p53-functional SAS oral cancer cells Am J Cancer Res 10 3230 3247 2020 33163267
60 Huang YC Yuan TM Liu BH Liu KL Wung CH Chuang SM Capsaicin Potentiates Anticancer Drug Efficacy Through Autophagy-Mediated Ribophorin II Downregulation and Necroptosis in Oral Squamous Cell Carcinoma Cells Front Pharmacol 12 676813 2021 10.3389/fphar.2021.676813 34512323
61 Chakraborty R Vickery K Darido C Ranganathan S Hu H Bacterial Antigens Reduced the Inhibition Effect of Capsaicin on Cal 27 Oral Cancer Cell Proliferation Int J Mol Sci 22 8686 2021 10.3390/ijms22168686 34445392
62 Materska M Perucka I Antioxidant activity of the main phenolic compounds isolated from hot pepper fruit (Capsicum annuum L) J Agric Food Chem 53 1750 1756 2005 10.1021/jf035331k 15740069
63 Shahidi F Varatharajan V Oh WY Peng H Phenolic compounds in agri-food by-products, their bioavailability and health effects J Food Bioact 5 57 119 2019
64 Romero-Luna HE Colina J Guzmán-Rodríguez L Sierra-Carmona CG Farías-Campomanes ÁM García-Pinilla S González-Tijera MM Malagón-Alvira KO Peredo-Lovillo A C apsicum fruits as functional ingredients with antimicrobial activity: An emphasis on mechanisms of action J Food Sci Technol 60 1 11 2022 10.1007/s13197-022-05578-y 36091639
65 Periferakis AT Periferakis A Periferakis K Caruntu A Badarau IA Savulescu-Fiedler I Scheau C Caruntu C Antimicrobial Properties of Capsaicin: Available Data, Future Research Perspectives Nutrients 15 4097 2023 10.3390/nu15194097 37836381
66 Santos MM Vieira-da-Motta O Vieira IJ Braz-Filho R Gonçalves PS Maria EJ Terra WS Rodrigues R Souza CL Antibacterial activity of Capsicum annuum extract and synthetic capsaicinoid derivatives against Streptococcus mutans J Nat Med 66 354 356 2012 10.1007/s11418-011-0579-x 21858615
67 Gu H Yang Z Yu W Xu K Fu YF Antibacterial Activity of Capsaicin against Sectional Cariogenic Bacteria Pak J Zool 51 681 687 2019
68 Doğan K Tunçer S Capsaicin Shows Species and Strain-specific Activity: Investigation of the Antibacterial Effects on the Oral Pathogen Streptococcus mutans and the Oral Probiotics Streptococcus salivarius M18 and K12 Hacettepe Biol Chem 52 11 19 2024
69 Cong X Zhang Y Shi L Yang NY Ding C Li J Ding QW Su YC Xiang RL Wu LL Yu GY Activation of transient receptor potential vanilloid subtype 1 increases expression and permeability of tight junction in normal and hyposecretory submandibular gland Lab Invest 92 753 768 2012 10.1038/labinvest.2012.12 22391958
70 Nascimento PL Nascimento TC Ramos NS Silva GR Gomes JE Falcão RE Moreira KA Porto AL Silva TM Quantification, Antioxidant and Antimicrobial Activity of Phenolics Isolated from Different Extracts of Capsicum frutescens (Pimenta Malagueta) Molecules 19 5434 5447 2014 10.3390/molecules19045434 24879587
71 Omolo MA Wong ZZ Borh WG Hedblom GA Dev K Baumler DJ Comparative analysis of capsaicin in twenty nine varieties of unexplored Capsicum and its antimicrobial activity against bacterial and fungal pathogens J Med Plant Res 12 544 556 2018
72 Behbehani JM Irshad M Shreaz S Karched M Anticandidal Activity of Capsaicin and Its Effect on Ergosterol Biosynthesis and Membrane Integrity of Candida albicans Int J Mol Sci 24 1046 2023 10.3390/ijms24021046 36674560
73 Hafiz T Mubaraki M Dkhil M Al-Quraishy S Antiviral Activities of Capsicum annuum Methanolic Extract against Herpes Simplex Virus 1 and 2 Pakistan J Zool 49 251 255 2017
74 Tang K Zhang X Guo Y Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry Acta Pharm Sin B 10 789 798 2020 10.1016/j.apsb.2020.02.014 32528827
75 Gonzalez-Paz LA Lossada CA Moncayo LS Romero F Paz JL Vera-Villalobos J Pérez AE San-Blas E Alvarado YJ Theoretical Molecular Docking Study of the Structural Disruption of the Viral 3CL-Protease of COVID19 Induced by Binding of Capsaicin, Piperine and Curcumin Part 1: A Comparative Study with Chloroquine and Hydrochloroquine Two Antimalaric Drugs. Preprint: Research Square, 2020. 10.21203/rs.3.rs-21206/v1
76 Zhang MQ Jia X Cheng CQ Wang YX Li YY Kong LD Li QQ Xie F Yu YL He YT Capsaicin functions as a selective degrader of STAT3 to enhance host resistance to viral infection Acta Pharmacol Sin 44 2253 2264 2023 10.1038/s41401-023-01111-9 37311796
